In this study, boride layers on C70W2 steel, obtained by boronizing at temperatures ranging from 870 to 970 °C and durations from 4 to 8 h, were investigated. The characterization of the layers was carried out using a new approach based on the change in the volume fraction of the boride phase. Analysis of the change in volume fraction showed that an increase in temperature and duration resulted in thicker layers, with temperature having a greater influence. Based on the volume fraction of the boride phase, the layer is divided into compact and toothed parts. With increasing temperature, the thicknesses of both parts of the layer increased. The thickness of the toothed part was the highest after 6 h of boronizing and further prolongation of boronizing led to a decrease in the thickness. Regression equations were estimated for the prediction of the volume fraction of the boride phase, the thickness of the compact part, and that of the toothed part of the boride layer as a function of the boronizing parameters. This study has shown that characterization based on the volume fraction of the boride phase offers advantages over the conventional method based on the average thickness of the layer.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181824 | PMC |
| http://dx.doi.org/10.3390/ma15113891 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Modeling Heart Failure With Preserved Ejection Fraction Using Human Induced Pluripotent Stem Cell-Derived Cardiac Organoids.
Circ Heart Fail
January 2025
Bruce Rapport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel (I.R.H., N.K., C.B., O.C.).
Background: The therapeutic armamentarium for heart failure with preserved ejection fraction (HFpEF) remains notably constrained. A factor contributing to this problem could be the scarcity of in vitro models for HFpEF, which hinders progress in developing new therapeutic strategies. Here, we aimed at developing a novel, comorbidity-inspired, human, in vitro model for HFpEF.
View Article and Find Full Text PDFInfluence of matrix stiffness on microstructure evolution and magnetization of magneto-active elastomers.
Soft Matter
January 2025
Leibniz-Institut für Polymerforschung Dresden e.V., Hohe Strasse 6, Dresden, 01069, Germany.
Field-induced microstructure evolution can play an important role in defining the coupled magneto-mechanical response of Magneto-Active Elastomers (MAEs). The behavior of these materials is classically modeled using mechanical, magnetic and coupled magneto-mechanical contributions to their free energy function. If the MAE sample is fully clamped so it cannot deform, the mechanical coupling is reduced to the internal microscopic deformations caused by the particles moving and deforming the elastic medium that surrounds them.
View Article and Find Full Text PDFEndothelial Dysfunction in Acute Myocardial Infarction: A Complex Association With Sleep Health, Traditional Cardiovascular Risk Factors and Prognostic Markers.
Clin Cardiol
January 2025
Research Laboratory, Molecular Bases of Human Pathology, LR19ES13, Faculty of Medicine, University of Sfax, Sfax, Tunisia.
Background: Endothelial function (EndFx) is a core component of cardiovascular (CV) health and cardioprotection following acute myocardial infarction (AMI) treated with primary percutaneous coronary intervention (PCI).
Hypothesis: AMI patients experience endothelial dysfunction (EndDys), associated with traditional CV risk factors and sleep patterns. EndFx may also predict short and mid-term outcomes.
Continuous risk monitoring and management of heart failure: Rationale and design of the ALLEVIATE-HF trial.
Eur J Heart Fail
January 2025
Medical University of South Carolina, Charleston, SC, USA.
Aims: Early identification and management of worsening heart failure (HF) is necessary to prevent disease progression and hospitalizations. The ALLEVIATE-HF (Algorithm Using LINQ Sensors for Evaluation and Treatment of Heart Failure) trial is a prospective, randomized, controlled, double-blind, multicentre trial that aims to assess the safety and efficacy of using the Reveal LINQ™ insertable cardiac monitor (ICM) in patients with HF to continuously monitor and evaluate HF risk status and guide timely interventions.
Methods: The ICM algorithm uses parameters derived from electrocardiogram (atrial fibrillation [AF], ventricular rate during AF, heart rate variability, and night heart rate), three-axis accelerometer (patient activity duration), and subcutaneous bioimpedance (fluid volume, respiration rate).
Safety and effectiveness of pulsed field ablation for pulmonary vein isolation in atrial fibrillation patients: One-year single center experience.
Rev Port Cardiol
January 2025
Cardiology Department, Hospital Santa Cruz, Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal.
Introduction And Objectives: Pulmonary vein (PV) isolation is one of the cornerstones of rhythm-control therapy for symptomatic atrial fibrillation (AF) patients. Pulsed field ablation (PFA) is a novel ablation modality that involves the application of electrical pulses causing cellular death, and it has preferential tissue specificity. In this study, we aimed to share a one-year single center experience of AF ablation with PFA.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!